OPTIKEREN NR 4, 2025 46 FAGSTOFF 1 Dietrichs E. og Beiske A.G. (2019): Den litt større parkinsonboken. Bind 1: Parkinsons sykdom og andre former for parkinsonisme. Nevrolitterære klubb, Oslo (ISBN: 978-82996059-5-3) 2 Damsgaard E., Ditlefsen H. (2024): Noen får - andre ikke: Stor variasjon i tilbud om Parkinson-medisin. NRK-nyhet, https://www. nrk.no/sorlandet/parkinson-pasienter-venter-pa-ny-og-bedre-behandling-1.17136977, (08.03.2025) 3 Tysnes O.B., Storstein A. (2017): Epidemiology of Parkinson’s disease. J Neural Transm (Vienna) 124:901–5. 4 Senter for bevegelsesforstyrrelser (2024): https://www.helse-stavanger.no/fag-ogforskning/kompetansetjenester/senter-for-bevegelsesforstyrrelser/#om-oss (20.04.2025) 5 Helland M. (2021): Parkinsons sykdom og synsproblematikk. Optikeren, no. 2, 42-48 6 Helland M., Hogstad W., Evanger K. (2024): Parkinsons sykdom og synsproblematikk. Brilleutfordringer? Optikeren, no. 4, 44-49 7 Dalbro S. E. J., Kerty E. (2024): Synsvansker ved Parkinsons sykdom. Tidsskrift for Den norske legeforening. Vol. 144, doi: 10.4045/tidsskr.23.0716 8 Scheiman M., Wick B. (2002): Convergence insufficiency, in Clinical management of binocular vision. Heterophoric, accommodative, and eye movement disorders. (Second Edition), Lippincott Williams & Wilkins, Philadelphia 9 Rouse, M.W., Borsting, E.J., Lynn Mitchell, G., Scheiman, M., Cotter, S.A., Cooper, J., Kulp, M.T., London, R., Wensveen, J (2004): Validity and reliability of the revised convergence insufficiency symptom survey in adults. Ophthalmic and Physiological Optics, 24: 384-390. https://doi. org/10.1111/j.1475-1313.2004.00202.x 10 Urwyler P., Nef T., Killen A., Collerton D., Thomas A., Burn D., McKeith I., Mosimann U.P. (2014): Visual complaints and visual hallucinations in Parkinson’s disease. Parkinsonism and Related Disorders. (20), 318-322, http://dx.doi.org/10.1016/j. parkreldis.2013.12.009 11 Smilowska K., Wowra B., Slawek J. (2020): Double vision in Parkinson’s disease: a systematic review. Polish Journal of Neurology and Neurosurgery. Vol.54, no. 6, 502-507 12 Hamedani A.G., Maguire M.G., Marras C., Willis A.W. (2021): Prevalence and risk factors for double vision in Parkinson’s disease. Movement Disorders Clinical Practice. 8(5), 709-712, doi 10.1002/mdc3.13220 13 Ungureanu L., Irincu L., Diaconu S., Opritoiu B., Chaudhuri K.R., Falup-Pecurariu C. (2024): Diplopia in movement disorders: A systematic review of the literature. Journal of Personalized Medicine. 14:270, https://doi. org/10.3390/jpm14030270 14 Irving E.L., Chriqui E., Law C., Kergoat M.-J., Leclerc B.-S., Panisset M., Postuma R., Kergoat R. (2016): Prevalence of Convergence Insufficiency in Parkinson’s Disease. Mov Disord Clin Pract, 20;4(3):424-429. doi: 10.1002/mdc3.12453 15 Law C., Chriqui E., Kergoat M.-J.,Leclerc B.-S., Panisset M., Irving E. L., Postuma R. B., Chouinard S., Kergoat H. (2017): Prevalence of Convergence Insufficiency-Type Symptomatology in Parkinson’s Disease. Can J Neurol Sci, Sep; 44(5):562-566. doi: 10.1017/ cjn.2017.39. 16 Neumann W., Gogarten J., Schönfeld S., Klostermann F., Marzinzik F., Schindlbeck K.A. (2021): Diplopia in Parkinson’s disease: Indication of a cortical phenotype with cognitive dysfunction? Neurologica. Acta Neurologica Scandinavica. 144, 440-449, doi 10.1111/ane.13479 17 Garcia D.S., Rios L.N., de Deus Fonticoba T., Bartolomé C.C., Roca L.G., Painceras M.F., Miró C.M., Canfield H., Jesús S., Aguilar M., Pastor P., Cosgaya M., Caldentey J.G., Caballo N., Legarda I., Vara J.H., Cabo I., Manzanares L.L., Aramburu I.G., Rivera M.A.Á., Mayordomo V.G., Nogueira V., Puente V., Dotor J., Borrué C., Vila B.S., Sauco M.Á., Vela L., Escalante S., Cubo E., Padilla F.C., Castrillo J.C.M., Alonso P.S., Losada M.G.A., Ariztegui N.L., Gastón I., Kulisevsky J., Estrada M.B., Seijo M., Martínez J.R., Valero C., Kurtis M., de Fábregues O., Ardura J.G., Redondo R.A., Ordás C., Diaz L.M.L., McAfee D., Martinez-Martin P., Mir P. on behalf of the COPPADIS Study Group (2021): Diplopia is frequent and associated with motor and non-motor severity in Parkinson’s disease: Results from the COPPADIS cohort at 2-year follow-up. Diagnostics. 11, 2380, https://doi. org/10.3390/diagnostics11122380 18 Nowacka B., Lubinski W., Honczarenko K., Potemkowski A., Safranow K. (2014): Ophthalmological features of Parkinson disease. Medical Science Monitor, 20, 2243-2249 19 Sari E.S., Koç R., Yazici A., Şahin G., Çakmak H., Kokatürk T., Ermiş S.S. (2015): Tear osmolarity, break-up time and Schirmer’s scores in Parkinson’s disease. TJO 45; 4: 142-145 20 Gilligan R. (2015): Prism management in patients with neurodegenerative disease. American Orthoptic Journal, Vol. 65, 44-46 21 Schindlbeck K.A., Schönfeld S., Naumann W., Friedrich D.J., Maier A., Rewitzer C., Klostermann F., Marzinzik F. (2017): Characterization of diplopia in non-demented patients with Parkinson’s disease. Parkinson and Related Disorders, 45, 1-6 22 Berman A.A. (2007): Neuro-ophthalmology and Parkinson’s disease. (Educational Supplement 17). American Parkinson Disease Association 23 Reich S. G. (2019): Treatment of diplopia in Parkinson’s disease. (Chapter 19) I Therapy of Movement Disorders, Current Clinical Neurology, Springer Forlag (79-81) 24 Bargagli A., Fontanelli E., Zanca D., Castelli I., Rosini F., Maddii S., Di Donato I., Carluccio A., Battisti C., Tosi G.M., Dotti M.T., Rufa A. (2020): Neurophthalmologic and orthoptic ambulatory assessments reveal ocular and visual changes in patients with early Alzheimer and Parkinson’s disease. Frontiers in Neurology, vol. 11, article 577362, doi 10.3389/fneur.2020.577362 25 Almer Z., Klein K.S., Marsh L., Gerstenhaber M., Repka M.X. (2012): Ocular motor and sensory function in Parkinson Disease. Ophthalmology. 119 (1), 178-182 26 Meglio M., Olivola E., Santilli M., Lena F., Centoze D., Bologna M., Modugno N. (2021): Effect of prismatic lenses on lateral axial dystonia in Parkinson’s disease: A pilot study. Innovations in clinical neuroscience (ICNS), Winter 2021 (January-March 2021, Vol. 18, No. 1-3, 39-42). 27 Stuparu A.Z., Jurja S., Stuparu A.F., Axelerad A. (2023): Narrative review concerning the clinical spectrum of ophthalmological impairment in Parkinson’s disease. Neurology International, 15, 140-161 28 Holden S.K., Van Dok E., Pelak V.S. (2019): Co-occurrence of Convergence Insufficiency and Cognitive Impairment in Parkinsonian Disorders: A Pilot Study. Front Neurol, 9:10:864. doi: 10.3389/fneur.2019.00864 29 Scheiman M., Cotter S., Rouse M., et al (2005): Randomised clinical trial of the effectiveness of base-in prism reading glasses versus placebo reading glasses for symptomatic convergence insufficiency in children British Journal of Ophthalmology; 89:1318-1323. 30 Teitelbaum B., Pang Y., Krall J. (2009): Effectiveness of Base in Prism for Presbyopes with Convergence Insufficiency. Optometry and Vision Science 86(2):p 153-156, February | DOI: 10.1097/OPX.0b013e318194e985 31 Chin F.H., Faibish B., Hisaka C., Thal L., Tsuda K. (1995): A survey of the treatment of convergence insufficiency. J Beh Optom, 6:91–92. 109. 32 Scheiman M., Cooper J., Mitchell G.L., et al. (2002): A survey of treatment modalities for convergence insufficiency. Opt Vis Sci 79:151–57. 33 Scheiman M., Mitchell G.L., Cotter S., Kulp M.T., Cooper J., Rouse M., Borsting E., London R., Wensveen J. (2005): A Randomized Clinical Trial of Vision Therapy/ Orthoptics versus Pencil Pushups for the Treatment of Convergence Insufficiency in Young Adults. Optometry and Vision Science 82(7):p E583-E595, July | DOI: 10.1097/01. opx.0000171331.36871.2f 34 Scheiman M., Mitchell G.L., Cotter S., et al (2005): In Reply: Convergence Insufficiency Randomized Clinical Trial. Arch Ophthalmol; 123:1760–1761. [PubMed: 16344456] 35 Aletaha M., Daneshvar F., Mosallaei M., Bagheri A., Khalili M.R. (2018): Comparison of three vision therapy approaches for convergence insufficiency. Journal of ophthalmic & vision research. Jul;13(3):307. 36 Kergoat H., Law C., Chriqui E., Kergoat M.-J., Leclerc B.-S., Panisset M., Postuma R., Irving E.L. (2017): Orthoptic Treatment of Convergence Insufficiency in Parkinson’s Disease: A Case Series. Case Reports Gerontol Geriatr Med. 11:3:2333721417703735. doi: 10.1177/2333721417703735 37 Machan C.M., Chriqui E., Law C., Norman B., Alhassan M., Almeida Q.J., Kergoat H., Irving E.L. (2020): Changing vergence function in persons with Parkinson’s disease and convergence insufficiency. Parkinsonism Relat Disord, 73:41-43. doi: 10.1016/j.parkreldis.2020.03.011 38 Kwan S.C.K., Atiya A., Hussaindeen J.R., Praveen S., Ambika S. (2022): Ocular features of patients with Parkinson’s disease examined at a Nuro-Optomtry clinic in a tertiary eye care center. Indian Journal of Ophthalmology, Vol. 70, 958-961 39 Visser F., Vlaar A.M.M., Borm C.D.J.M., Apostolov V., Lee Y.X., Notting I.C., Weinstein H.C., Berendse H-W. (2019): Diplopia in Parkinson’s disease: visual illusion or oculomotor impairment? J Neurol, 266(10):2457-2464. doi: 10.1007/s00415-019-09430-w £ Referanser
RkJQdWJsaXNoZXIy MTQ3Mzgy